BCAX vs CF · $1.51B cap vs P/E 12, rev $5.94B
Bicara Therapeutics Inc. Common Stock (BCAX) versus CF Industries Holdings Inc (CF) — a side-by-side from cached financials, not a winner call.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
BCAX does not have a complete income-statement cache yet.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
BCAX currently screens at market cap $1.51B. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Not investment advice. Open the BCAX and CF stock pages for the full models.
Not investment advice.